Testing an inhaled migraine medicine for quick relief
Part of Brain & nervous system clinical trials.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 and able to give informed consent
- Diagnosed with migraine (with or without aura) for at least 1 year
- Healthy weight range (BMI 18.5–35)
- No history of heart disease, stroke, or blood vessel problems
- No severe mental health conditions like psychosis, severe depression, or substance abuse
- No allergies to ergot-based medications or similar drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two new migraine medicines, rimegepant and zavegepant, given to people in the emergency department to see how well they work for stopping a migraine headache quickly.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This trial looks at whether breathing high-flow oxygen in the emergency department can help relieve migraine-like headaches. You may qualify if you are 18+ and are admitted to the ER for a migraine that fits standard diagnostic rules.
This trial tests a new oral medication called elismetrep (K-304) for quickly stopping migraine pain and other symptoms. If you have regular migraines, this could offer a new option that works fast when a migraine starts.
This study tests whether a specific diet change can help reduce migraine frequency. Participants will follow a structured diet plan for several weeks to see if it leads to fewer headache days.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.